Qube Research & Technologies (QRT)
WHWK

Qube Research & Technologies (QRT)’s Whitehawk Therapeutics WHWK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Buy
48,993
+686
+1% +$2.85K ﹤0.01% 2860
2026
Q1 		$167K Sell
48,307
-24,041
-33% -$75.3K ﹤0.01% 2991
2025
Q4 		$175K Buy
+72,348
New +$166K ﹤0.01% 3081
2024
Q3 		– Sell
-12,071
Closed -$17.6K – 4290
2024
Q2 		$17.6K Buy
+12,071
New +$22.4K ﹤0.01% 2897
2023
Q4 		– Sell
-106
Closed -$513 – 4832
2023
Q3 		$513 Buy
+106
New +$616 ﹤0.01% 3677
2022
Q2 		– Sell
-17,333
Closed -$294K – 3231
2022
Q1 		$294K Buy
+17,333
New +$332K ﹤0.01% 1799
2021
Q2 		– Sell
-801
Closed -$16K – 2889
2021
Q1 		$16K Sell
801
-3,735
-82% -$86K ﹤0.01% 1826
2020
Q4 		$67K Sell
4,536
-12,452
-73% -$266K ﹤0.01% 1679
2020
Q3 		$382K Buy
16,988
+14,759
+662% +$311K 0.01% 1139
2020
Q2 		$42K Buy
+2,229
New +$29.2K ﹤0.01% 1616

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Qube Research & Technologies (QRT)'s WHWK Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Whitehawk Therapeutics (WHWK) stake by 1.4% in Q2 2026, buying an estimated $2.85K and bringing the position to 48,993 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #2860.

Qube Research & Technologies (QRT) first reported a position in WHWK in Q2 2020 and has held it in 10 quarters since. The position peaked at $382K in Q3 2020. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Qube Research & Technologies (QRT) held 48,993 shares of Whitehawk Therapeutics worth $224K as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 686 Whitehawk Therapeutics shares in Q2 2026, an estimated $2.85K.
  • Whitehawk Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2860 holding.
  • Qube Research & Technologies (QRT) first reported a position in Whitehawk Therapeutics in Q2 2020 and has held it in 10 quarters since.
  • Qube Research & Technologies (QRT)'s Whitehawk Therapeutics position peaked at $382K in Q3 2020.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.